focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Director Declaration

12 Nov 2015 14:06

RNS Number : 5345F
BTG PLC
12 November 2015
 

12 November 2015

 

 

BTG plc - Directorship Notification under Listing Rule 9.6.14

 

Pursuant to the Financial Services Authority Listing Rule 9.6.14(2), BTG plc (the "Company") would like to announce that James O'Shea, who is a non-executive director of the Company, has been appointed as a non-executive director of Ocular Therapeutix™, Inc. (a US based public company whose shares are traded on the NASDAQ Stock Exchange) with effect from 5 November, 2015

- ends -

 

 

Contact for Queries:

Andy Burrows, Vice President, Corporate and Investor Relations

+44 (0)20 7575 1741

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNGMMMMDZDGKZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.